Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Ringelstein

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2017
Diagnostic criteria for Susac syndromeIlka Kleffner, Jan Dörr, Marius Ringelstein, et al.
Neurology|October 28, 2018
Racial differences in neuromyelitis optica spectrum disorderSu-Hyun Kim, Maureen A Mealy, Michael Levy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 2, 2021
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE RegistryFranziska S Thaler, Luise Zimmermann, Stefan Kammermeier, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatmentJulia Schubert, Dirk Brämer, Hagen B Huttner, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2017
Diagnostic criteria for Susac syndromeIlka Kleffner, Jan Dörr, Marius Ringelstein, et al.
Neurology|October 28, 2018
Racial differences in neuromyelitis optica spectrum disorderSu-Hyun Kim, Maureen A Mealy, Michael Levy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 2, 2021
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE RegistryFranziska S Thaler, Luise Zimmermann, Stefan Kammermeier, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatmentJulia Schubert, Dirk Brämer, Hagen B Huttner, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Pageof 12